Publication | Closed Access

Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis

Cd4+cd25+ Foxp3 ExpressionAutoimmune DiseaseImmunologyImmune RegulationImmunologic MechanismAutoimmunityBrain-immune InteractionCd4 T Cell ResponsesMultiple SclerosisImmunotherapyMedicineCell BiologyImmune Dysregulation